You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Estrogens, conjugated synthetic a - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for estrogens, conjugated synthetic a and what is the scope of patent protection?

Estrogens, conjugated synthetic a is the generic ingredient in two branded drugs marketed by Teva Womens and Aspen, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

Summary for estrogens, conjugated synthetic a
Recent Clinical Trials for estrogens, conjugated synthetic a

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Duramed ResearchPhase 4
The AlfredPhase 2
Stanley Medical Research InstitutePhase 2

See all estrogens, conjugated synthetic a clinical trials

Paragraph IV (Patent) Challenges for ESTROGENS, CONJUGATED SYNTHETIC A
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
CENESTIN Tablets estrogens, conjugated synthetic a 0.3 mg, 0.45 mg and 0.9 mg 020992 1 2009-03-19
CENESTIN Tablets estrogens, conjugated synthetic a 0.625 mg 020992 1 2009-03-02
CENESTIN Tablets estrogens, conjugated synthetic a 1.25 mg 020992 1 2008-11-03

US Patents and Regulatory Information for estrogens, conjugated synthetic a

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Womens SYNTHETIC CONJUGATED ESTROGENS A estrogens, conjugated synthetic a CREAM;VAGINAL 021788-001 Nov 28, 2008 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Aspen CENESTIN estrogens, conjugated synthetic a TABLET;ORAL 020992-004 Mar 13, 2000 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Aspen CENESTIN estrogens, conjugated synthetic a TABLET;ORAL 020992-002 Mar 24, 1999 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Aspen CENESTIN estrogens, conjugated synthetic a TABLET;ORAL 020992-001 Jun 21, 2002 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for estrogens, conjugated synthetic a

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Aspen CENESTIN estrogens, conjugated synthetic a TABLET;ORAL 020992-001 Jun 21, 2002 ⤷  Try a Trial ⤷  Try a Trial
Aspen CENESTIN estrogens, conjugated synthetic a TABLET;ORAL 020992-005 Feb 5, 2004 ⤷  Try a Trial ⤷  Try a Trial
Aspen CENESTIN estrogens, conjugated synthetic a TABLET;ORAL 020992-004 Mar 13, 2000 ⤷  Try a Trial ⤷  Try a Trial
Aspen CENESTIN estrogens, conjugated synthetic a TABLET;ORAL 020992-003 Mar 24, 1999 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.